Defensin Peptides from Marine Animals Could Help Fight Antibiotic Resistance
Marine animal defensins — antimicrobial peptides from fish and shellfish — show diverse antibacterial, antiviral, and immune-regulating properties that could be harnessed to combat antibiotic-resistant infections.
Quick Facts
What This Study Found
The review identifies several key aspects of marine animal defensins:
• Marine defensins exhibit activity against bacteria, viruses, and fungi through multiple mechanisms — membrane binding, channel formation, and lipid II interaction
• The ocean's unique ecological environment has produced defensins with rich biodiversity and special molecular features compared to terrestrial defensins
• Beyond antimicrobial activity, marine defensins also have immune-regulatory and reproductive functions
• Nanotechnology approaches — including antimicrobial peptide-antibiotic conjugates, nanonets, and nanoparticle-based delivery systems — can enhance their antibacterial potency and broaden their spectrum of activity
• Marine defensins are classified primarily from fish and shellfish sources, with distinct structural characteristics and evolutionary trajectories
Key Numbers
How They Did This
This is a narrative review that synthesizes published research on defensins from marine animals. The authors compiled and analyzed data on structural characteristics, classification, evolutionary history, antimicrobial mechanisms, immune functions, and therapeutic applications of marine defensins, with emphasis on fish and shellfish sources.
Why This Research Matters
Antibiotic resistance threatens to make common infections untreatable. Antimicrobial peptides like defensins kill bacteria through mechanisms that are fundamentally different from conventional antibiotics, making it much harder for bacteria to develop resistance. Marine organisms — which have survived in pathogen-rich ocean environments for hundreds of millions of years — represent a largely untapped reservoir of these natural antibiotics. Understanding and harnessing marine defensins could provide new weapons against drug-resistant superbugs.
The Bigger Picture
This review sits at the intersection of marine biotechnology, antimicrobial peptide research, and the global fight against antibiotic resistance. The WHO has declared antimicrobial resistance a top-10 global health threat, and peptide-based alternatives to conventional antibiotics are receiving increasing attention. Marine biodiversity represents one of the richest sources of novel antimicrobial peptides, and advances in nanotechnology are making it possible to overcome the traditional limitations of peptide drugs — including stability and delivery challenges.
What This Study Doesn't Tell Us
As a review article, this synthesizes existing research without generating new experimental data. Most marine defensin research is at the in vitro stage — very few marine-derived defensins have reached preclinical or clinical testing. The translation from discovering an antimicrobial peptide in a fish to developing a human therapy faces enormous challenges including stability, toxicity, manufacturing cost, and regulatory approval. The review focuses primarily on fish and shellfish, potentially underrepresenting defensins from other marine organisms.
Questions This Raises
- ?Which specific marine defensins are closest to clinical development as anti-infective therapeutics?
- ?How do the manufacturing costs of marine-derived antimicrobial peptides compare to conventional antibiotics?
- ?Can nanotechnology delivery systems solve the stability and bioavailability problems that have limited peptide antibiotics so far?
Trust & Context
- Key Stat:
- 3 distinct killing mechanisms Marine defensins attack pathogens through membrane binding, channel formation, and lipid II interaction — making resistance development much harder than with conventional antibiotics
- Evidence Grade:
- This is a narrative review summarizing the field of marine defensin research. It provides a comprehensive overview but no original experimental data. Most of the underlying studies are in vitro or early preclinical, with very limited clinical translation to date.
- Study Age:
- Published in 2025, this is a very current review that captures the latest developments in marine antimicrobial peptide research and nanotechnology delivery approaches.
- Original Title:
- Structure, function, and therapeutic potential of defensins from marine animals.
- Published In:
- Fish & shellfish immunology, 163, 110365 (2025)
- Authors:
- Lei, Yining, He, Dangui, Zhao, Xiao, Miao, Lixia, Cao, Zhijian
- Database ID:
- RPEP-12041
Evidence Hierarchy
Frequently Asked Questions
Why are scientists looking at ocean animals for new antibiotics?
Marine organisms have evolved powerful antimicrobial peptides called defensins to survive in pathogen-rich ocean environments for hundreds of millions of years. These peptides kill bacteria through different mechanisms than conventional antibiotics, making them potential solutions for drug-resistant infections that current antibiotics can't treat.
Are marine defensins available as medicines yet?
Not yet. While marine defensins show promising antimicrobial activity in laboratory studies, they face significant hurdles before becoming medicines — including stability issues, manufacturing challenges, and the need for clinical trials. Nanotechnology approaches discussed in this review could help overcome some of these obstacles.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12041APA
Lei, Yining; He, Dangui; Zhao, Xiao; Miao, Lixia; Cao, Zhijian. (2025). Structure, function, and therapeutic potential of defensins from marine animals.. Fish & shellfish immunology, 163, 110365. https://doi.org/10.1016/j.fsi.2025.110365
MLA
Lei, Yining, et al. "Structure, function, and therapeutic potential of defensins from marine animals.." Fish & shellfish immunology, 2025. https://doi.org/10.1016/j.fsi.2025.110365
RethinkPeptides
RethinkPeptides Research Database. "Structure, function, and therapeutic potential of defensins ..." RPEP-12041. Retrieved from https://rethinkpeptides.com/research/lei-2025-structure-function-and-therapeutic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.